Thomas Arnoux

1.4k total citations
6 papers, 172 citations indexed

About

Thomas Arnoux is a scholar working on Surgery, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Arnoux has authored 6 papers receiving a total of 172 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Surgery, 2 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Arnoux's work include Cardiac Ischemia and Reperfusion (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Arnoux is often cited by papers focused on Cardiac Ischemia and Reperfusion (2 papers), Immune Cell Function and Interaction (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Thomas Arnoux collaborates with scholars based in France, Sweden and Germany. Thomas Arnoux's co-authors include Rebecca M. Pruss, Thierry Bordet, Magali Michaud, Caroline Gouarné, Claire Sunyach, Brigitte Pettmann, Nathalie Bernard‐Marissal, Cédric Raoul, Julianne Aebischer and Marie‐Geneviève Mattéi and has published in prestigious journals such as Cancer Research, European Journal of Pharmacology and Neuropharmacology.

In The Last Decade

Thomas Arnoux

6 papers receiving 170 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Arnoux France	5	105	85	42	33	26	6	172
Karen Overstreet United States	2	57 0.5×	103 1.2×	179 4.3×	11 0.3×	35 1.3×	2	226
Andrea Swenson United States	9	59 0.6×	49 0.6×	114 2.7×	11 0.3×	41 1.6×	17	230
Guo-Jun Tan China	8	65 0.6×	27 0.3×	28 0.7×	10 0.3×	24 0.9×	13	149
Jasmine Harley United Kingdom	9	123 1.2×	37 0.4×	68 1.6×	13 0.4×	31 1.2×	11	204
S. Sathasivam United Kingdom	6	63 0.6×	55 0.6×	139 3.3×	26 0.8×	35 1.3×	9	220
J. Ealing United Kingdom	6	120 1.1×	38 0.4×	129 3.1×	10 0.3×	31 1.2×	9	234
Rajasekaran Mahalingam United States	10	83 0.8×	33 0.4×	18 0.4×	18 0.5×	13 0.5×	18	212
Yoshimi Kinoshita Japan	7	117 1.1×	66 0.8×	103 2.5×	8 0.2×	24 0.9×	12	205
F Valsecchi Italy	7	198 1.9×	18 0.2×	127 3.0×	40 1.2×	22 0.8×	15	334
M. Jeanmart France	6	69 0.7×	18 0.2×	23 0.5×	37 1.1×	28 1.1×	9	284

Countries citing papers authored by Thomas Arnoux

Since Specialization

Citations

This map shows the geographic impact of Thomas Arnoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Arnoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Arnoux more than expected).

Fields of papers citing papers by Thomas Arnoux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Arnoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Arnoux. The network helps show where Thomas Arnoux may publish in the future.

Co-authorship network of co-authors of Thomas Arnoux

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Arnoux. A scholar is included among the top collaborators of Thomas Arnoux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Arnoux. Thomas Arnoux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Soulas, Caroline, Romain Remark, Vedran Brezar, et al.. (2018). Abstract 2714: Combination of monalizumab and durvalumab as a potent immunotherapy treatment for solid human cancers. Cancer Research. 78(13_Supplement). 2714–2714. 5 indexed citations

2.

Sola, Caroline, Thomas Arnoux, Fabien Chanuc, et al.. (2016). Abstract 2342: NKG2A immune checkpoint blockade enhances the anti-tumor efficacy of PD1/PD-L1 inhibitors in a preclinical model. Cancer Research. 76(14_Supplement). 2342–2342. 2 indexed citations

3.

Hansson, Magnus J., Didier Morin, Thomas Arnoux, et al.. (2015). Differences in the profile of protection afforded by TRO40303 and mild hypothermia in models of cardiac ischemia/reperfusion injury. European Journal of Pharmacology. 760. 7–19. 24 indexed citations

4.

Schaller, Sophie, et al.. (2015). TRO40303, a mitochondrial‐targeted cytoprotective compound, provides protection in hepatitis models. Pharmacology Research & Perspectives. 3(3). e00144–e00144. 6 indexed citations

5.

Sunyach, Claire, Magali Michaud, Thomas Arnoux, et al.. (2012). Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model. Neuropharmacology. 62(7). 2346–2353. 77 indexed citations

6.

Michaud, Magali, Thomas Arnoux, Estelle Durand, et al.. (2010). Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiology of Disease. 38(1). 125–135. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact